Medela spins off wound care biz in merger with medaxis
By HME News Staff
Updated 8:32 AM CST, Mon November 6, 2023
BAAR, Switzerland – Medela will transition its wound care business into a separate global business.
The new standalone wound care company will continue to provide wound care solutions powered by Medela’s medical vacuum technology, including its negative pressure wound therapy line of products and services. It will also incorporate the latest technology from medaxis, a Swiss med-tech company that is part of Olle Larsson Holding.
“I am honored and excited to lead the new wound care company,” said Jeff Castillo, who will transition from executive vice president of Medela Americas to lead the new would care company as CEO on Dec. 1. “Medela has a long legacy driven by exceptional medical vacuum technology. I look forward to working alongside these dedicated professionals to set new standards of care with wound care solutions powered by Medela’s medical vacuum technology and new medical innovations from medaxis.”
The new wound care company will continue to use Medela’s Elgin, Ill., facility for shipping products. Current medaxis employees and leadership, as well as existing Medela wound care team members, will transition under the leadership of Castillo also on Dec. 1.
medaxis has earned breakthrough designation from the U.S. Food and Drug Administration with its technology to help support neovascularization and tissue growth, increase cellular activity and circulation, and support bacterial load reduction.
Comments